NCT04962919View on ClinicalTrials.gov

Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.

Active, not recruitingOBSERVATIONAL
Enrollment

584

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

May 7, 2025

Study Completion Date

May 7, 2025

Conditions
Prostatic Neoplasms, Castration-Resistant
Trial Locations (8)

Unknown

CPO Pucrs, Porto Alegre

Centro Paulista de Oncologia, São Paulo

09060-650

Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO, Santo André

01308-050

Sírio Libanês, São Paulo

(11) 2070-6000

Hospital Santa Marcelina, São Paulo

01.323-030

BP - A Beneficência Portuguesa de São Paulo, São Paulo

01221-010

Irmandade da Santa Casa de Misericórdia de São Paulo - Hospital Central, São Paulo

01525-001

A.C.Camargo Cancer Center, São Paulo

All Listed Sponsors
lead

Latin American Cooperative Oncology Group

OTHER

NCT04962919 - Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions. | Biotech Hunter | Biotech Hunter